IQVHealthcare · Diagnostics & ResearchThe 20 Wall Street analysts covering IQVIA Holdings, Inc. hold a median 12-month price target of $305 — +10.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 87 of 100 as at 28 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores IQVIA Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (97): The share price has been relatively steady.
Issuance (62): The company has been issuing shares or taking on financing, diluting existing holders.
Size (6): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on IQV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +10.9% from it.
Of the 20 most recent actions, 13 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 28 Oct 2026 | Baird | Maintains | Outperform | $324 → $328 |
| 28 Oct 2026 | Evercore ISI Group | Maintains | Outperform | $290 → $310 |
| 28 Oct 2026 | JP Morgan | Maintains | Overweight | $295 → $325 |
| 28 Oct 2026 | Truist Securities | Maintains | Buy | $329 → $346 |
| 14 Oct 2026 | Stifel | Maintains | Buy | $276 → $303 |
| 7 Oct 2026 | Barclays | Maintains | Overweight | $275 → $300 |
| 7 Oct 2026 | Mizuho | Maintains | Outperform | $275 → $300 |
| 30 Sept 2026 | UBS | Reinstates | Buy | $345 |
| 29 Sept 2026 | RBC Capital | Maintains | Outperform | — |
| 29 Sept 2026 | RBC Capital | Maintains | Outperform | $247 → $319 |
| 28 Sept 2026 | Truist Securities | Reiterates | Buy | — |
| 28 Sept 2026 | Truist Securities | Reiterates | Buy | $300 → $329 |
| 17 Sept 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 17 Sept 2026 | Morgan Stanley | Maintains | Equal-Weight | $240 → $270 |
| 29 July 2026 | Baird | Maintains | Outperform | $252 → $287 |
| 29 July 2026 | Baird | Maintains | Outperform | — |
| 29 July 2026 | BMO Capital | Maintains | Outperform | — |
| 29 July 2026 | BMO Capital | Maintains | Outperform | $210 → $270 |
| 29 July 2026 | JP Morgan | Maintains | Overweight | — |
| 29 July 2026 | JP Morgan | Maintains | Overweight | $225 → $285 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
IQV appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 29 Oct 2026, IQVIA Holdings, Inc. returned +26.3% against +13.1% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 22% of US stocks
Cheaper than 44% of US stocks
Cheaper than 13% of US stocks
Cheaper than 15% of US stocks
Higher than 50% of US stocks
Higher than 32% of US stocks
Higher than 38% of US stocks
Higher than 70% of US stocks
Higher than 66% of US stocks
Higher than 84% of US stocks
Higher than 77% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
IQVIA Holdings, Inc. has a market value of $45.9B and an enterprise value of $60.0B.
Revenue in the twelve months to 30 June 2026: $17.0B. The latest quarter grew 8.0% year on year.
Net income over the same four quarters: $1.4B, a 8.1% net margin.
Diluted earnings per share, trailing twelve months: $8.06.
Free cash flow in the twelve months to 30 June 2026: $2.2B.
IQVIA Holdings, Inc. spent $1.2B on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 33.5×; forward P/E: 19.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
IQVIA Holdings, Inc. employs 95,000 people — $179K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own IQVIA Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Artisan Global Value Fund said IQVIA was among its three best-performing stocks in the quarter, alongside Meta and Shell. The excerpt also noted that U.S. government debt-to-GDP exceeded 120% and interest payments surpassed the national defense budget.
Why it matters — The fund’s report identifies IQVIA as one of its strongest-performing holdings for the quarter.
Zacks Investment Research’s headline characterizes IQVIA Holdings as a strong momentum stock. The excerpt notes that Zacks Style Scores are a feature of its Premium research service intended to help identify stocks across value, growth, and momentum styles.
Why it matters — IQV watchers may note that the item frames the company positively through a momentum-investing lens and references Zacks’ scoring service.
IQVIA reported third-quarter results above the high end of its guidance ranges, citing accelerating organic growth in Commercial Solutions and R&D Solutions, higher clinical win rates, and strong free cash flow.
Why it matters — These results and operating trends offer IQV watchers an update on the company’s performance across its businesses and cash generation.
Seeking Alpha published a transcript of IQVIA Holdings Inc.’s Q3 2026 earnings call. The provided excerpt contains no further details about the call.
Why it matters — The transcript is a source for IQV watchers seeking information about the company’s Q3 2026 earnings call, but no specific discussion or results are included in the excerpt.
IQVIA reported Q3'26 earnings above estimates, with revenue up 8% year over year. The excerpt attributes the increase to strong clinical demand, robust R&D bookings and improved execution, and notes a view hike.
Why it matters — The earnings beat and revenue growth, along with the cited business drivers, are relevant to investors following IQVIA’s performance.
The 20 Wall Street analysts covering IQVIA Holdings, Inc. have a median 12-month price target of $305, with estimates ranging from $268 to $346. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 20 analysts covering IQVIA Holdings, Inc., 18 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks IQVIA Holdings, Inc. 87 out of 100 across roughly 4,600 US stocks as at 28 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 28 Oct 2026, IQVIA Holdings, Inc. ranks 87 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (97 of 100).
No one can know that. What the data says: the median 12-month target from 20 analysts implies +10.9% from the last close, and Ticker Nerd's factor model ranks IQVIA Holdings, Inc. 87 out of 100 as at 28 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering IQVIA Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IQV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $268 to $346 over the next 12 months.
IQVIA Holdings, Inc. returned +26.3% over the 12 months to 29 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
IQVIA Holdings Inc. is a global healthcare services and analytics company that supports the life sciences industry with clinical research services, commercial insights, and healthcare intelligence.
The most recent item we track (Seeking Alpha, 29 Oct 2026): "Artisan Global Value Fund Q3 2026 Portfolio Discussion". Artisan Global Value Fund said IQVIA was among its three best-performing stocks in the quarter, alongside Meta and Shell. The excerpt also noted that U.S. government debt-to-GDP exceeded 120% and interest payments surpassed the national defense budget.
IQVIA Holdings Inc. is a global healthcare services and analytics company that supports the life sciences industry with clinical research services, commercial insights, and healthcare intelligence. The company combines advanced data, technology solutions, and domain expertise to help pharmaceutical, biotechnology, medical device, and healthcare organizations improve clinical development, evidence generation, and commercial execution. Its core business spans technology and analytics solutions, research and development solutions, and contract sales and medical solutions, making it a key partner across the medical product lifecycle. IQVIA Holdings Inc. serves clients in major regions worldwide, including the Americas, Europe, Africa, and the Asia-Pacific, and plays an important role in turning health data into actionable insights for research, operations, and market access.
CEO Mr. Ari Bousbib · 95,000 employees · United States · https://www.iqvia.com
